The finding of pronounced hyperkalaemia usually demands prompt treatment to lower serum potassium. In a patient with pseudohyperkalaemia such treatment is potentially harmful.
CASE HISTORY
A man of 60 with type 2 diabetes mellitus was started on an angiotensin-converting enzyme (ACE) inhibitor for hypertension. His serum potassium rose from the previous 4.9 mmol/L (normal 3.5-5.0) to 5.8 mmol/L. Despite a reduction in the dose of the ACE inhibitor the potassium remained above normal, and when it reached 6.7 mmol/L the patient was admitted for a dextrose-insulin intravenous drip. On the electrocardiogram there were no hyperkalaemic changes and his renal function was normal. Despite treatment the serum potassium remained between 5.7 and 5.9 mmol/L. At this stage the patient was noted to have high blood counts of platelets (1000610 9 /L), white cells (14.9610 9 /L with 86% neutrophils) and red cells (7.486 10 12 /L), which were microcytic (mean cell volume 67 fL) and hypochromic (mean cell haemoglobin 21.19 g/dL). Haemoglobin was 15.8 ng/dL. The serum ferritin was low at 18 ng/mL but the haematocrit was normal at 0.50. Clinically he was not plethoric and had no hepatosplenomegaly.
Polycythaemia rubra vera was diagnosed, with hyperkalaemia due to leakage of potassium from red cells, white cells and platelets. A bone marrow biopsy showed hypercellularity. When simultaneous blood samples were taken in a lithium heparin tube (plasma sample) and a clotted tube (serum sample) and tested on a Roche Modular, the plasma sample gave a potassium reading of 3.8 mmol/L and the serum sample 4.7 mmol/L.
On further enquiry about symptoms of hyperviscosity the patient said that 18 months earlier a visual disturbance had been diagnosed as amaurosis fugax. At the time, his platelet count had been high (564610 9 /L) but his red cell count had been normal without hypochromia or microcytosis. 
COMMENT
Pseudohyperkalaemia is defined as a difference between serum and plasma potassium greater than 0.4 mmol/L. 1 As blood clots, potassium is released from platelets, white cells or red cells into the serum, giving a falsely high value. This process is avoided by use of plasma, which gives a more accurate estimation. The discrepancy may be greater when there is a long interval between blood sampling and separation of serum, 2 reflecting greater degranulation of blood cells. In myeloproliferative disorders, a high haematocrit will also tend to raise the serum potassium because of the smaller volume of distribution. 2 Pseudohyperkalaemia should be suspected when, despite the high potassium, the electrocardiogram, urea, creatinine and electrolytes are normal. 3, 4 A plasma sample should then be examined. 5 The phenomenon needs to be borne in mind to avoid treatment of non-existent hyperkalaemia, which can do harm. Also, patients with apparently normal potassium may in fact be hypokalaemic. Thus, in polycythaemia rubra vera, plasma potassium rather than serum potassium should be measured. Factor X deficiency is usually inherited. 1 Of the acquired forms some are transient, possibly associated with infection, and, in these, spontaneous intracerebral haemorrhage does not seem to have been reported.
Intracerebral haemorrhage in an adult due to transient factor X deficiency

CASE HISTORY
A previously well man of 66 attended his local accident and emergency unit after two weeks of fevers and two days of apparent confusion. His general practitioner had started him on erythromycin a week previously for a presumed chest infection (he was penicillin allergic). On examination the chest was clear clinically and radiologically. When he proved to have frank haematuria a urinary tract infection was suspected, but the midstream urine revealed no organisms and produced no growth. Blood cultures were also negative. The international normalized ratio (INR) was high at 5.4 (normal 0.9-1.2) and the activated partial thromboplastin time (APTT) ratio was 2.6 (0.9-1.2). The platelet count was within the normal range at 342610 9 /L. A value of 0.2 mg/mL for latex D-dimers (normal 50.5) excluded disseminated intravascular coagulopathy. Liver function was normal. There was no personal or family history of bleeding diathesis and he had never taken warfarin.
A 50/50 mix of the patient's plasma with normal plasma corrected the clotting indices to INR 1.7, APTT ratio 1.2. Coagulation factor assays (in iU/dL, normal range for all 50-200) were: factor II, 37; factor V, 38; factor VII, 48; factor VIII 158; factor IX, 147; factor X, 3. Thus factor X was very low, with factors II, V and VII just below normal. Acquired factor X deficiency was diagnosed and the patient was treated with 10 mg intravenous vitamin K, 15 mL/kg of fresh frozen plasma, and 3180 iU factor IX concentrate (HIPFIX-SNBTS), which also contains factor X. His factor X rose to 26 iU/dL. After a further dose of 3000 iU factor IX concentrate the INR was 1.9, APTT ratio 1.6, and factor X 52 iU/dL.
Over the two days from presentation the patient showed worsening expressive dysphasia, and CT of the brain revealed a moderate-sized left (dominant) hemisphere intracerebral haemorrhage without significant midline shift. By the time of transfer to the neurosurgical unit he was almost aphasic. Since he was fully alert, initial management was conservative, while his clotting was further corrected with coagulation factor infusions. After 5 days on the unit, factor X was 51 iU/dL and INR 1.29. Nevertheless, the patient's level of consciousness dropped rapidly on day five and repeat CT (Figure 1) showed extension of the original haemorrhage, this time with midline shift. The haematoma was evacuated the same day and the patient made an excellent recovery, becoming fully alert and mobile with only mild residual expressive dysphasia. Throughout the recovery phase his INR, APTT ratios and factor X concentrations remained normal without further infusions.
